Jelena Banjeglav

University College Hospital at Westmoreland Street

Papers

2

Total Citations

34

H-Index

2

About

Jelena Banjeglav is a clinical researcher whose work focuses on improving the pre-operative staging of prostate cancer, with a particular emphasis on the diagnostic accuracy of multi-parametric MRI (mpMRI). Her major contribution lies in demonstrating that a negative mpMRI can reliably rule out extra-prostatic extension (EPE) in prostate cancer patients prior to robot-assisted radical prostatectomy. This finding is critical for surgical planning, as it helps avoid unnecessary nerve damage and preserves quality of life. Her most-cited paper on this topic has accumulated 30 citations, reflecting its impact on urological oncology practice. Banjeglav’s research employs a risk-stratified 5-point Likert scale to evaluate EPE on a side-specific basis, offering a nuanced approach that challenges prior controversies surrounding mpMRI reliability. Her work bridges the gap between imaging and surgical outcomes, providing clinicians with evidence-based tools to reduce overtreatment. For students and researchers, Banjeglav’s studies underscore the importance of rigorous validation in cancer staging and highlight how targeted MRI interpretation can transform patient care.

Research Focus

Key Achievements

2
H-Index
2
Papers
34
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Negative mpMRI Rules Out Extra-Prostatic Extension in Prostate Cancer before Robot-Assisted Radical Prostatectomy
30 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 30
🏛 Institutions: University College Hospital at Westmoreland Street

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago